>Not achieving significance doesn't mean it's useless It's sort of does... It means that at the phase two trial level it didn't show enough promise to merit further trials. They're desperately searching for an application for this drug. This drug was not designed for stuttering treatment. No one should be pinning their hopes on drugs that are still in the exploratory phase.